Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Epstein-Barr Virus Infections 1

Interventions

pembrolizumab 40Cisplatin 32Radiotherapy 22Cetuximab 22Radiotherapy, Intensity-Modulated 15Docetaxel 12Nivolumab 11Paclitaxel 10Fluorouracil 10Carboplatin 8Radiosurgery 6epacadostat 5Radiation 5spartalizumab 4avelumab 4Surgical Procedures, Operative 4Radiotherapy, Conformal 4Immunoglobulin G 4Biopsy 4ribociclib 3durvalumab 3bempegaldesleukin 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Everolimus 3Erlotinib Hydrochloride 3Disulfides 3Cyclophosphamide 3Albumin-Bound Paclitaxel 3utomilumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Squamous Cell Carcinoma of Head and Neck × Tegafur × Clear all
NCT01720563 2025-06-04

A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy

PhytoHealth Corporation

Phase 2 Terminated
17 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡